Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hematoboost: Preoperative IV Iron and EPO for TKA
NCT05911438Unknown
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jul 2023
- Primary completion
- Dec 2024
- Modality
- Inorganic Nanoparticles, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ferric derisomaltose and erythropoietin in postoperative anemia (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Hemoglobin concentration. Status: unknown.
02
Drugs
ferric derisomaltoseerythropoietin
03
Conditions
postoperative anemia
Beyond the preview
Go deeper on NCT05911438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05911438.